US high court junks opioid settlement

By Agence France-Presse

Jun 29, 2024 12:16 am

WASHINGTON, D.C. — The US Supreme Court on Thursday rejected Purdue Pharma's $6-billion opioids settlement immunizing the Sackler family, which controlled the drugmaker, from future litigation.

In a 5-4 ruling, the judges agreed with the Justice Department which argued that the Sacklers, who earned tens of billions of dollars flooding the country with highly addictive opioids, should not gain sweeping legal protection in the controversial deal.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Macao poll candidate seeks diversification

US ports brace for potential workers strike

Nepal dam-building spree powers electric vehicle boom

US growth higher than expected in 2023

China central bank lowers interest rates

Intel, US to finalize $8.5-B chips funding

US regulator urges checks on Boeing 737 rudders